SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 505.16 |
Enterprise Value ($M) | 424.66 |
Book Value ($M) | 660.10 |
Book Value / Share | 9.04 |
Price / Book | 0.77 |
NCAV ($M) | 638.70 |
NCAV / Share | 8.75 |
Price / NCAV | 0.79 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.07 |
Return on Assets (ROA) | -0.04 |
Return on Equity (ROE) | -0.08 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.58 |
Current Ratio | 4.58 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 979.70 |
Assets | 1,001.10 |
Liabilities | 341.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 263.40 |
Operating Income | -250.20 |
Net Income | -198.90 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -259.30 |
Cash from Investing | 34.70 |
Cash from Financing | 7.90 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | EcoR1 Capital, LLC | 0.00 | -100.00 | |
13G/A | Vanguard Group Inc | 12.15 | 18.72 | |
13G/A | BlackRock, Inc. | 7.90 | -16.52 | |
13G/A | Citadel Advisors Llc | 5.10 | ||
13G/A | Price T Rowe Associates Inc /md/ | 5.60 | 0.48 | |
13G/A | Rtw Investments, Lp | 4.10 | -33.97 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
371,544 | 1,765,739 | 21.04 | |
361,755 | 1,377,217 | 26.27 | |
450,658 | 2,223,172 | 20.27 | |
817,412 | 3,581,705 | 22.82 | |
(click for more detail) |
Similar Companies | |
---|---|
ANNX – Annexon, Inc. | APLS – Apellis Pharmaceuticals, Inc. |
ARQT – Arcutis Biotherapeutics, Inc. | ARWR – Arrowhead Pharmaceuticals, Inc. |
ASMB – Assembly Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io